New developments in alpha-adrenergic receptor pharmacology: Implications for the initial treatment of hypertension
- 24 February 1983
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 51 (4) , 639-643
- https://doi.org/10.1016/s0002-9149(83)80201-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Therapy for Mild HypertensionPublished by American Medical Association (AMA) ,1983
- Increased vascular catecholamine sensitivity and alpha-adrenergic receptor affinity in female and estrogen-treated male rats.Circulation Research, 1982
- Evidence for more than one type of post-junctional α-AdrenoceptorBiochemical Pharmacology, 1982
- Elevated Adrenaline and Increased α-Adrenoceptor-Mediated Vasoconstriction in Essential HypertensionJournal of Cardiovascular Pharmacology, 1982
- α-Adrenoceptor Blockade by Phentolamine Causes β-Adrenergic Vasodilation by Increased Catecholamine Release Due to Presynaptic α-BlockadeJournal of Cardiovascular Pharmacology, 1982
- Regulation of the postsynaptic alpha-adrenergic receptor in rat mesenteric artery. Effects of chemical sympathectomy and epinephrine treatment.Circulation Research, 1981
- Alpha-Adrenergic Receptor SubtypesNew England Journal of Medicine, 1980
- A functional basis for classification of α-adrenergic receptorsLife Sciences, 1977
- Age-Adjusted Plasma Norepinephrine Levels Are Similar in Normotensive and Hypertensive SubjectsNew England Journal of Medicine, 1977
- Prazosin: severe side effects are dose-dependent.BMJ, 1976